PHARMACYTE BIOTECH INC's ticker is PMCBD and the CUSIP is 71715X203. A total of 27 filers reported holding PHARMACYTE BIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,438,000 | +10.8% | 1,015,666 | +3.4% | 0.53% | +19.0% |
Q2 2022 | $2,201,000 | +1.3% | 982,698 | +4.0% | 0.44% | +58.4% |
Q1 2022 | $2,173,000 | +31.2% | 944,666 | +42.6% | 0.28% | +1.8% |
Q4 2021 | $1,656,000 | +3500.0% | 662,337 | +4434.7% | 0.27% | +4466.7% |
Q3 2021 | $46,000 | – | 14,606 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ayrton Capital LLC | 92,087 | $193,383 | 1.31% |
SABBY MANAGEMENT, LLC | 97,124 | $203,960 | 0.15% |
K2 PRINCIPAL FUND, L.P. | 258,481 | $542,810 | 0.11% |
EQUITEC PROPRIETARY MARKETS, LLC | 82,727 | $173,727 | 0.04% |
CSS LLC/IL | 13,186 | $27,691 | 0.00% |
Aspire Private Capital, LLC | 800 | $1,680 | 0.00% |
Schonfeld Strategic Advisors LLC | 23,300 | $48,930 | 0.00% |
OSAIC HOLDINGS, INC. | 1,971 | $4,139 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 29,307 | $61,545 | 0.00% |
BANK OF AMERICA CORP /DE/ | 116 | $243 | 0.00% |